The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected with human immunodeficiency virus type 1 (HIV - 1). (sciencedaily.com)
The paucity of virus - laden CD4 + cells in individuals infected with human immunodeficiency virus type - 1 (HIV - 1) contrasts with the greatly reduced numbers and function of these lymphocytes. (science.sciencemag.org)
Petrie, K.J., Pennebaker, J.W. et al. (2004) Effect of Written Emotional Expression on Immune Function in Patients With Human Immunodeficiency Virus Infection: A Randomized Trial. (my.happify.com)